A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs

Wei Chen Huang, Shang Hsiu Hu, Kun Ho Liu, San Yuan Chen, Dean Mo Liu

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

A flexible drug delivery device was designed and fabricated using electrophoretic deposition of drug-carrying magnetic core-shell Fe3O4 at SiO2 nanoparticles onto an electrically conductive flexible PET substrate. The PET substrate was first patterned to a desired layout and subjected to deposition. In doing so, a uniform and nanoporous membrane could be produced. After lamination of the patterned membranes, a final chip-like device of thickness less than 0.5 mm is formed that is used for controlled delivery of an anti-epileptic drug, i.e., ethosuximide (ESM). The release of useful drugs can be controlled by directly modulating the magnetic field, and the chip is capable of demonstrating a variety of release profiles (i.e., slow release, sustained release, step-wise release and burst release profiles). These profiles can follow a wide spectrum of patterns ranging from zero to pulsatile release kinetics depending on the mode of magnetic operation. When the magnetic field was removed, the release behavior was instantly ceased, and vice versa. A preliminary in-vivo study using Long-Evans rat model has demonstrated a significant reduction in spike-wave discharge after the ESM was burst released from the chip under the same magnetic induction as in-vitro, indicating the potential application of the drug delivery chip. The flexible and membrane-like drug delivery chip utilizes drug-carrying magnetic nanoparticles as the building blocks that ensure a rapid and precise response to magnetic stimulus. Moreover, the flexible chip may offer advantages over conventional drug delivery devices by improvement of dosing precision, ease of operation, wider versatility of elution pattern, and better compliance.

Original languageEnglish
Pages (from-to)221-228
Number of pages8
JournalJournal of Controlled Release
Volume139
Issue number3
DOIs
Publication statusPublished - Nov 3 2009
Externally publishedYes

Fingerprint

Pharmaceutical Preparations
Ethosuximide
Magnetic Fields
Equipment and Supplies
Nanoparticles
Membranes
Long Evans Rats
Compliance

Keywords

  • Controlled release
  • Drug delivery chip
  • Epilepsy
  • Magnetic induction

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs. / Huang, Wei Chen; Hu, Shang Hsiu; Liu, Kun Ho; Chen, San Yuan; Liu, Dean Mo.

In: Journal of Controlled Release, Vol. 139, No. 3, 03.11.2009, p. 221-228.

Research output: Contribution to journalArticle

Huang, Wei Chen ; Hu, Shang Hsiu ; Liu, Kun Ho ; Chen, San Yuan ; Liu, Dean Mo. / A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs. In: Journal of Controlled Release. 2009 ; Vol. 139, No. 3. pp. 221-228.
@article{7bf8c25cd0b2492c82f052e998bc38ee,
title = "A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs",
abstract = "A flexible drug delivery device was designed and fabricated using electrophoretic deposition of drug-carrying magnetic core-shell Fe3O4 at SiO2 nanoparticles onto an electrically conductive flexible PET substrate. The PET substrate was first patterned to a desired layout and subjected to deposition. In doing so, a uniform and nanoporous membrane could be produced. After lamination of the patterned membranes, a final chip-like device of thickness less than 0.5 mm is formed that is used for controlled delivery of an anti-epileptic drug, i.e., ethosuximide (ESM). The release of useful drugs can be controlled by directly modulating the magnetic field, and the chip is capable of demonstrating a variety of release profiles (i.e., slow release, sustained release, step-wise release and burst release profiles). These profiles can follow a wide spectrum of patterns ranging from zero to pulsatile release kinetics depending on the mode of magnetic operation. When the magnetic field was removed, the release behavior was instantly ceased, and vice versa. A preliminary in-vivo study using Long-Evans rat model has demonstrated a significant reduction in spike-wave discharge after the ESM was burst released from the chip under the same magnetic induction as in-vitro, indicating the potential application of the drug delivery chip. The flexible and membrane-like drug delivery chip utilizes drug-carrying magnetic nanoparticles as the building blocks that ensure a rapid and precise response to magnetic stimulus. Moreover, the flexible chip may offer advantages over conventional drug delivery devices by improvement of dosing precision, ease of operation, wider versatility of elution pattern, and better compliance.",
keywords = "Controlled release, Drug delivery chip, Epilepsy, Magnetic induction",
author = "Huang, {Wei Chen} and Hu, {Shang Hsiu} and Liu, {Kun Ho} and Chen, {San Yuan} and Liu, {Dean Mo}",
year = "2009",
month = "11",
day = "3",
doi = "10.1016/j.jconrel.2009.07.002",
language = "English",
volume = "139",
pages = "221--228",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs

AU - Huang, Wei Chen

AU - Hu, Shang Hsiu

AU - Liu, Kun Ho

AU - Chen, San Yuan

AU - Liu, Dean Mo

PY - 2009/11/3

Y1 - 2009/11/3

N2 - A flexible drug delivery device was designed and fabricated using electrophoretic deposition of drug-carrying magnetic core-shell Fe3O4 at SiO2 nanoparticles onto an electrically conductive flexible PET substrate. The PET substrate was first patterned to a desired layout and subjected to deposition. In doing so, a uniform and nanoporous membrane could be produced. After lamination of the patterned membranes, a final chip-like device of thickness less than 0.5 mm is formed that is used for controlled delivery of an anti-epileptic drug, i.e., ethosuximide (ESM). The release of useful drugs can be controlled by directly modulating the magnetic field, and the chip is capable of demonstrating a variety of release profiles (i.e., slow release, sustained release, step-wise release and burst release profiles). These profiles can follow a wide spectrum of patterns ranging from zero to pulsatile release kinetics depending on the mode of magnetic operation. When the magnetic field was removed, the release behavior was instantly ceased, and vice versa. A preliminary in-vivo study using Long-Evans rat model has demonstrated a significant reduction in spike-wave discharge after the ESM was burst released from the chip under the same magnetic induction as in-vitro, indicating the potential application of the drug delivery chip. The flexible and membrane-like drug delivery chip utilizes drug-carrying magnetic nanoparticles as the building blocks that ensure a rapid and precise response to magnetic stimulus. Moreover, the flexible chip may offer advantages over conventional drug delivery devices by improvement of dosing precision, ease of operation, wider versatility of elution pattern, and better compliance.

AB - A flexible drug delivery device was designed and fabricated using electrophoretic deposition of drug-carrying magnetic core-shell Fe3O4 at SiO2 nanoparticles onto an electrically conductive flexible PET substrate. The PET substrate was first patterned to a desired layout and subjected to deposition. In doing so, a uniform and nanoporous membrane could be produced. After lamination of the patterned membranes, a final chip-like device of thickness less than 0.5 mm is formed that is used for controlled delivery of an anti-epileptic drug, i.e., ethosuximide (ESM). The release of useful drugs can be controlled by directly modulating the magnetic field, and the chip is capable of demonstrating a variety of release profiles (i.e., slow release, sustained release, step-wise release and burst release profiles). These profiles can follow a wide spectrum of patterns ranging from zero to pulsatile release kinetics depending on the mode of magnetic operation. When the magnetic field was removed, the release behavior was instantly ceased, and vice versa. A preliminary in-vivo study using Long-Evans rat model has demonstrated a significant reduction in spike-wave discharge after the ESM was burst released from the chip under the same magnetic induction as in-vitro, indicating the potential application of the drug delivery chip. The flexible and membrane-like drug delivery chip utilizes drug-carrying magnetic nanoparticles as the building blocks that ensure a rapid and precise response to magnetic stimulus. Moreover, the flexible chip may offer advantages over conventional drug delivery devices by improvement of dosing precision, ease of operation, wider versatility of elution pattern, and better compliance.

KW - Controlled release

KW - Drug delivery chip

KW - Epilepsy

KW - Magnetic induction

UR - http://www.scopus.com/inward/record.url?scp=70349322413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349322413&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2009.07.002

DO - 10.1016/j.jconrel.2009.07.002

M3 - Article

C2 - 19607866

AN - SCOPUS:70349322413

VL - 139

SP - 221

EP - 228

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -